激光生物学报, 2019, 28 (4): 289, 网络出版: 2019-09-27   

光动力诊疗中的5-氨基酮戊酸及酯类衍生物的研究进展

Research Progress of 5-Aminolevulinic Acid and Its Esters in Photodynamic Diagnosis and Therapy
作者单位
1 福建师范大学光电与信息工程学院, 医学光电科学与技术教育部重点实验室, 福建省光子技术重点实验室, 福州350007
2 东华学院医疗及健康科学学院, 香港 999077
摘要
5-氨基酮戊酸(ALA)是体表光动力疗法的一个重要前体药物, 通过代谢产物原卟啉Ⅸ(PpⅨ)介导发挥光敏作用。ALA制剂的研发和优化促生了一系列产品和技术, 不仅推动了体表光动力疗法的应用, 而且ALA介导的PpⅨ荧光还可用于肿瘤的荧光可视化和辅助手术。本文将对光动力诊疗中ALA及其酯类衍生物和PpⅨ的研究进展作一个系统介绍。
Abstract
5-Aminolevulinic acid (ALA) is an important prodrug in topical photodynamic therapy (PDT). Its photosensitization is mediated through protoporphyrin Ⅸ (PpⅨ). The ALA-related drug development and application optimization promote a series of products and techniques that expanded the clinical applications of topical PDT. PpⅨ fluorescence visualization not only plays an important role in topical PDT, it is also useful in fluorescence-guided surgery for bladder cancer and gliomas. This review will provide an overview on some progress in ALA, ALA esters and PpⅨ applications.
参考文献

[1] 中华医学会皮肤性病学分会光动力治疗研究中心. 氨基酮戊酸光动力疗法临床应用专家共识[J]. 中华皮肤科杂志, 2015, 48(10): 675-678.

    Photodynamic Therapy Research Center of Dermatovenereal Diseases Branch of Chinese Medical Association. Expert consensus on the clinical application of aminopentanilic acid photodynamic therapy[J]. Chinese Journal of Dermatology, 2015, 48(10): 675-678.

[2] FAN L, YIN R, LAN T, et al. Photodynamic therapy for rosacea in chinese patients[J]. Photodiagnosis and Photodynamic Therapy, 2018, 24: 82-87.

[3] SHEMIN D, RUSSELL C S. δ-Aminolevulinic acid, its role in the biosynthesis of porphyrins and purines[J]. Journal of the American Chemical Society, 1953, 75(19): 4873-4874.

[4] BURCH J S, MARCERO J R, MASCHECK J A, et al. Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis[J], Blood, 2018, 132(10): 987-998.

[5] BEALE S I. Biosynthesis of the tetrapyrrole pigment precursor, delta-aminolevulinic acid, from glutamate 1[J]. Plant Physiology, 1990, 93(4): 1273-1279.

[6] ANDRADE P, CAUDEPON D, ALTABELLA T, et al. Complex interplays between phytosterols and plastid development[J]. Plant Signaling & Behavior, 2017, 12(11): e1387708.

[7] MALIK Z, DJALDETTI M. 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced friend erythroleukemic cells[J]. Cell Differentiation, 1979, 8(3): 223-233.

[8] HUANG Z, SHI S, QIU H, et al. Fluorescence-guided resection of brain tumor:review of the significance of intraoperative quantification of protoporphyrin Ⅸ fluorescence[J]. Neurophotonics, 2017, 4(1): 011011.

[9] WEN X, LI Y, HAMBLIN M R. Photodynamic therapy in dermatology beyondnon-melanoma cancer:an update[J]. Photodiagnosis and Photodynamic Therapy, 2017, 19: 140-152.

[10] 李伟军, 方玉宏, 董葵, 等. 去角质化的光学相干成像检测[J]. 激光生物学报, 2017, 26(6): 508-511.

    LI Weijun, FANG Yuhong, DONG Kui, et al. Optical coherence tomography imaging of exfoliation[J]. Acta Laser Biology Sinica, 2017, 26(6): 508-511.

[11] PENG Q, MOAN J, WARLOE T, et al. Build-up of esterified aminolevulinic-acid-derivative induced porphyrin fluorescence in normal mouse skin[J]. Journal of Photochemistry and Photobiology B: Biology, 1996, 34(1): 95-96.

[12] FOTINOS N, CAMPO M A, POPOWYCZ F, et al. 5-Aminolevulinic acid derivatives in photomedicine:characteristics, application and perspectives[J]. Photochemistry and Photobiology, 2006, 82(4): 994-1015.

[13] SACHAR M, ANDERSON K E, MA X. Protoporphyrin Ⅸ:the good, the bad and the ugly[J]. Journal of Pharmacology & Experimental Therapeutics, 2015, 356(2): 267-275.

[14] FUJINO M, NISHIO Y, ITO H, et al. 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction[J]. International Immunopharmacology, 2016, 37: 71-78.

[15] PARAGH G, ZEITOUNI N C, Two-step irradiance treatment can achieve excellent pain control during red light 5-Aminolevulinic acid photodynamic therapy for actinic keratoses[J]. Photomedicine and Laser Surgery, 2018, 36(3): 174-176.

[16] DE SOUZA A L R, LAROCHELLE E, MARRA K, et al. Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ[J]. Photodiagnosis and Photodynamic Therapy, 2017, 20: 227-233.

[17] MAY M, FRITSCHE H M, VETTERLEIN M W, et al. Impact of photodynamic diagnosis- assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy:results from PROMETRICS 2011[J]. World Journal of Urology, 2017, 35(2): 245-250.

[18] CHAN D T M, YI P S H, POON W S. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma:Hong Kong experience[J]. Asian Journal of Surgery, 2018, 41(5): 467-472.

[19] KANICK S C, DAVIS S C, ZHAO Y, et al. Pre-treatment protoporphyrin Ⅸ concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy[J]. Photodiagnosis and Photodynamic Therapy, 2015, 12(4): 561-566.

[20] TYRRELL J, PATERSON C, CURNOW A. Regression analysis of protoporphyrin Ⅸ measurements obtained during dermatological photodynamic therapy[J]. Cancers (Basel), 2019, 11(1): E72.

[21] HUNTOSOVA V, GERELLI E, ZELLWEGER M, et al. Effect of PpⅨ photoproducts formation on pO2 measurement by time-resolved delayed fluorescence spectroscopy of PpⅨ in solution and in vivo[J]. Journal of Photochemistry and Photobiology B: Biology, 2016, 164: 49-56.

[22] REINHOLD U. A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis[J]. Future Oncology, 2017, 13(27): 2413-2428.

[23] NOVAK B, MORTON C, REINHOLD U, et al. A nanoemulsion based drug delivery system for PDT:development and clinical application of BF-200 ALA[J]. Photodiagnosis and Photodynamic Therapy, 2017, 17: A4-A78.

[24] HILLEMANNS P, GARCIA F, PETRY K U, et al. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia1/2[J]. American Journal of Obstetrics and Gynecology, 2015, 212(4): 465.e1-465.e7.

[25] 周盼, 谢小燕, 熊力, 等. 抗菌光敏剂的分类及研究进展[J]. 激光生物学报, 2017, 26(3): 193-197.

    ZHOU Pan, XIE Xiaoyan, XIONG Li, et al. The classification of antibacterial photosensitizer and its research progress[J]. Acta Laser Biology Sinica, 2017, 26(3): 193-197.

[26] MORDON S R, 邱海霞, 黄正. 光动力疗法治疗乳房外派杰氏病的技术进展[J]. 中国激光医学杂志, 2018, 27(2): 7-14.

    MORDON S R, QIU Haixia, HUANG Zheng. Advances in the technique of photodynamic therapy for the treatment of extramammary Paget’s disease[J]. Chinese Journal of Laser Medicine & Surgery, 2018, 27(2): 7-14.

蒋捷, 邹健, 朱杏楣, 胡永基, 李伟军, 黄正. 光动力诊疗中的5-氨基酮戊酸及酯类衍生物的研究进展[J]. 激光生物学报, 2019, 28(4): 289. JIANG Jie, ZOU Jian, Ellie S. M. Chu, Ricky W. K. Wu, LI Weijun, HUANG Zheng. Research Progress of 5-Aminolevulinic Acid and Its Esters in Photodynamic Diagnosis and Therapy[J]. Acta Laser Biology Sinica, 2019, 28(4): 289.

本文已被 1 篇论文引用
被引统计数据来源于中国光学期刊网
引用该论文: TXT   |   EndNote

相关论文

加载中...

关于本站 Cookie 的使用提示

中国光学期刊网使用基于 cookie 的技术来更好地为您提供各项服务,点击此处了解我们的隐私策略。 如您需继续使用本网站,请您授权我们使用本地 cookie 来保存部分信息。
全站搜索
您最值得信赖的光电行业旗舰网络服务平台!